Pharmacyte Biotech Inc. (PMCB)
Market Closed
16 Oct, 08:00 PM
NASDAQ (CM) NASDAQ (CM) Primary $
0. 34
-0.02
-4.8125%
$
4.34M Market Cap
- P/E Ratio
- Div Yield
32,984 Volume
0 Eps
$ 0.36
Previous Close 
Want to track PMCB and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Pharmacyte Biotech Inc. (PMCB) Statistics
Valuation metrics
Market Cap 4.34M
Enterprise value -13.4M
Trailing P/E (ttm) -0.17
Forward P/E -
PEG ratio -0
Price/Sales (ttm) -
Price/Book (mrq) 0.15
Enterprise Value/Revenue -
Enterprise Value/EBITDA 2.45
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 125.42K
Average volume (90 days) 149.24K
Price summary
52-Week low 0.33
52-Week high 1.51
Beta -
50-Day moving average 0.42
200-Day moving average 0.68
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -0.02
Dividend Date -
Ex-Dividend Date -
Last split factor 1:1,500
Last split Date 12 Jul 2021
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.44%
Return on equity -0.46%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.5
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 2.84
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 40.3%
Book value per share (mrq) 2.78
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
